default author photo

Frilasita Aisyah Yudhaputri

Eijkman Institute for Molecular Biology-National Research and Innovation Agency

Rumah 25 Sakit Cipto Mangunkusumo, Jl. Pangeran Di

Jakarta

Indonesia

SCHOLARLY PAPERS

1

DOWNLOADS

163

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

SARS CoV-2 Antibody Seroprevalence in Jakarta, Indonesia: March 2021

Number of pages: 15 Posted: 01 Nov 2021
University of Indonesia (UI) - Faculty of Public Health, University of Indonesia (UI) - Faculty of Public Health, University of Indonesia (UI) - Faculty of Public Health, University of Indonesia (UI) - Faculty of Public Health, University of Indonesia (UI) - Faculty of Public Health, Jakarta Provincial Department of Health, Jakarta Provincial Department of Health, DKI Jakarta Provincial Health Office, DKI Jakarta Provincial Health Office, DKI Jakarta Provincial Health Office, Mochtar Riady Institute for Nanotechnology, Eijkman Institute for Molecular Biology-National Research and Innovation Agency, National Research and Innovation Agency of Indonesia, Eijkman Institute for Molecular Biology-National Research and Innovation Agency, Eijkman Institute for Molecular Biology-National Research and Innovation Agency, Eijkman Institute for Molecular Biology-National Research and Innovation Agency, Government of the United States of America - Center for Global Health, Government of the United States of America - Division of Global Health Protection, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Tetracore, Inc. Rockville, Tetracore, Inc. Rockville and The SingHealth Duke-NUS Global Health Institute (SDGHI)
Downloads 163 (459,428)
Citation 1

Abstract:

Loading...

SARS CoV-2, COVID-19, seroprevalence, serosurvey, prevalence, Indonesia